Cargando…

NQPC-13 THE EFFICACY OF RAVEN’S COLORED PROGRESSIVE MATRICES FOR PATIENTS WITH BRAIN TUMOR

BACKGROUND: Mini-Mental State Examination (MMSE) and Raven’s Colored Progressive Matrices (RCPM) are cognitive function tests used to assess speech and visual cognitive functions in patients with brain tumor and aphasia, respectively. We investigated the distribution and correlation between MMSE and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yahiro, Sachiko, Matsuoka, Aiko, Miyakita, Yasuji, Ohno, Makoto, Takahashi, Masamichi, Narita, Yoshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213096/
http://dx.doi.org/10.1093/noajnl/vdz039.142
_version_ 1783531728141287424
author Yahiro, Sachiko
Matsuoka, Aiko
Miyakita, Yasuji
Ohno, Makoto
Takahashi, Masamichi
Narita, Yoshitaka
author_facet Yahiro, Sachiko
Matsuoka, Aiko
Miyakita, Yasuji
Ohno, Makoto
Takahashi, Masamichi
Narita, Yoshitaka
author_sort Yahiro, Sachiko
collection PubMed
description BACKGROUND: Mini-Mental State Examination (MMSE) and Raven’s Colored Progressive Matrices (RCPM) are cognitive function tests used to assess speech and visual cognitive functions in patients with brain tumor and aphasia, respectively. We investigated the distribution and correlation between MMSE and RCPM scores in patients with brain tumor, who underwent tumor resection, to identify the test characteristics. METHOD: Among the 122 patients who underwent tumor resection in our hospital from April 2018 to March 2019, and potentially required rehabilitation, 43 patients (i.e., 19 men and 24 women) who underwent pre- and post-operative MMSE and RCPM were further investigated. Median age during surgery was 54 years (20–86 years). Relationship between the pre- and post-operative MMSE and RCPM scores were evaluated using the Spearman’s rank correlation coefficient. Additionally, we investigated the characteristics of patients who scored low on either of the tests. RESULTS: Median pre- and post-operative MMSE scores were 29 points (14–30) and 29 points (21–30), respectively. Median pre- and post-operative RCPM scores were 33 points (25–36) and 35 points (18–36), respectively. The pre- and post-operative correlation coefficient between MMSE and RCPM scores were 0.376 and 0.699, respectively. Among the 12 patients with lower pre-operative scores on MMSE, as compared to RCPM, 8 patients had impaired attention and 4 patients had aphasia. One patient who scored lower on RCPM test, as compared to MMSE, had reduced analogical reasoning ability. Postoperatively, no patient scored low on MMSE as compared to RCPM, and one patient who scored lower on RCPM than MMSE had left hemi-spatial neglect. CONCLUSION: The pre-operative cognitive functions of patients with impaired attention and aphasia can be evaluated with RCPM using visual tasks without interference caused by these impairments. Minute pre- and post-interventional cognitive changes can be assessed with both MMSE and RCPM together.
format Online
Article
Text
id pubmed-7213096
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72130962020-07-07 NQPC-13 THE EFFICACY OF RAVEN’S COLORED PROGRESSIVE MATRICES FOR PATIENTS WITH BRAIN TUMOR Yahiro, Sachiko Matsuoka, Aiko Miyakita, Yasuji Ohno, Makoto Takahashi, Masamichi Narita, Yoshitaka Neurooncol Adv Abstracts BACKGROUND: Mini-Mental State Examination (MMSE) and Raven’s Colored Progressive Matrices (RCPM) are cognitive function tests used to assess speech and visual cognitive functions in patients with brain tumor and aphasia, respectively. We investigated the distribution and correlation between MMSE and RCPM scores in patients with brain tumor, who underwent tumor resection, to identify the test characteristics. METHOD: Among the 122 patients who underwent tumor resection in our hospital from April 2018 to March 2019, and potentially required rehabilitation, 43 patients (i.e., 19 men and 24 women) who underwent pre- and post-operative MMSE and RCPM were further investigated. Median age during surgery was 54 years (20–86 years). Relationship between the pre- and post-operative MMSE and RCPM scores were evaluated using the Spearman’s rank correlation coefficient. Additionally, we investigated the characteristics of patients who scored low on either of the tests. RESULTS: Median pre- and post-operative MMSE scores were 29 points (14–30) and 29 points (21–30), respectively. Median pre- and post-operative RCPM scores were 33 points (25–36) and 35 points (18–36), respectively. The pre- and post-operative correlation coefficient between MMSE and RCPM scores were 0.376 and 0.699, respectively. Among the 12 patients with lower pre-operative scores on MMSE, as compared to RCPM, 8 patients had impaired attention and 4 patients had aphasia. One patient who scored lower on RCPM test, as compared to MMSE, had reduced analogical reasoning ability. Postoperatively, no patient scored low on MMSE as compared to RCPM, and one patient who scored lower on RCPM than MMSE had left hemi-spatial neglect. CONCLUSION: The pre-operative cognitive functions of patients with impaired attention and aphasia can be evaluated with RCPM using visual tasks without interference caused by these impairments. Minute pre- and post-interventional cognitive changes can be assessed with both MMSE and RCPM together. Oxford University Press 2019-12-16 /pmc/articles/PMC7213096/ http://dx.doi.org/10.1093/noajnl/vdz039.142 Text en © The Author(s) 2019. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Yahiro, Sachiko
Matsuoka, Aiko
Miyakita, Yasuji
Ohno, Makoto
Takahashi, Masamichi
Narita, Yoshitaka
NQPC-13 THE EFFICACY OF RAVEN’S COLORED PROGRESSIVE MATRICES FOR PATIENTS WITH BRAIN TUMOR
title NQPC-13 THE EFFICACY OF RAVEN’S COLORED PROGRESSIVE MATRICES FOR PATIENTS WITH BRAIN TUMOR
title_full NQPC-13 THE EFFICACY OF RAVEN’S COLORED PROGRESSIVE MATRICES FOR PATIENTS WITH BRAIN TUMOR
title_fullStr NQPC-13 THE EFFICACY OF RAVEN’S COLORED PROGRESSIVE MATRICES FOR PATIENTS WITH BRAIN TUMOR
title_full_unstemmed NQPC-13 THE EFFICACY OF RAVEN’S COLORED PROGRESSIVE MATRICES FOR PATIENTS WITH BRAIN TUMOR
title_short NQPC-13 THE EFFICACY OF RAVEN’S COLORED PROGRESSIVE MATRICES FOR PATIENTS WITH BRAIN TUMOR
title_sort nqpc-13 the efficacy of raven’s colored progressive matrices for patients with brain tumor
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213096/
http://dx.doi.org/10.1093/noajnl/vdz039.142
work_keys_str_mv AT yahirosachiko nqpc13theefficacyofravenscoloredprogressivematricesforpatientswithbraintumor
AT matsuokaaiko nqpc13theefficacyofravenscoloredprogressivematricesforpatientswithbraintumor
AT miyakitayasuji nqpc13theefficacyofravenscoloredprogressivematricesforpatientswithbraintumor
AT ohnomakoto nqpc13theefficacyofravenscoloredprogressivematricesforpatientswithbraintumor
AT takahashimasamichi nqpc13theefficacyofravenscoloredprogressivematricesforpatientswithbraintumor
AT naritayoshitaka nqpc13theefficacyofravenscoloredprogressivematricesforpatientswithbraintumor